Polimorfisme gen ferroportin (FPN1) -1355 G/C sebagai faktor risiko anemia defisiensi besi pada ibu hamil

Nor Istiqomah; Sarah Safira Umarghanies; Arta Farmawati; Ahmad Hamim Sadewa; Yuliana Heri Soesilo; Kusumadewi Eka Damayanti; Dono Indarto

doi:10.22146/ijcn.18364

Polimorfisme gen ferroportin (FPN1) -1355 G/C sebagai faktor risiko anemia defisiensi besi pada ibu hamil

https://doi.org/10.22146/ijcn.18364

Nor Istiqomah^(1*), Sarah Safira Umarghanies⁽²⁾, Arta Farmawati⁽³⁾, Ahmad Hamim Sadewa⁽⁴⁾, Yuliana Heri Soesilo⁽⁵⁾, Kusumadewi Eka Damayanti⁽⁶⁾, Dono Indarto⁽⁷⁾

(1) Program Studi Kesehatan Masyarakat, Fakultas Ilmu Kesehatan Universitas Pekalongan,
(2) Bagian Biokimia, Fakultas Kedokteran Universitas Gadjah Mada
(3) Bagian Biokimia, Fakultas Kedokteran Universitas Gadjah Mada
(4) Bagian Biokimia, Fakultas Kedokteran Universitas Gadjah Mada
(5) Fakultas Kedokteran Universitas Sebelas Maret, Surakarta
(6) Fakultas Kedokteran Universitas Sebelas Maret, Surakarta
(7) Fakultas Kedokteran Universitas Sebelas Maret, Surakarta
(*) Corresponding Author

Abstract

Background: According to WHO data, prevalence of anemia pregnancy in Indonesia is 44.3%, it’s higher than world prevalence (41.8%). Ferroportin (FPN1) is one of important iron exsporter for iron absorption, release, and recycle inside the body. The varian of FPN1-1355 G/C in promoter region, leads to increased of ferroportin expression and iron export, increased cellular iron needs, overexpression of soluble transferrin receptor (sTfR), decrease hemoglobin (Hb) and erythrocyte indices that manifest to iron deficiency anemia (IDA).

Objective: This research will study the frequency of FPN1-1355 G/C polymorphism as a risk factor of IDA in pregnant women in Indonesia.

Method: The research design was a case and control study. Blood samples were taken from 26 pregnant women with anemia and 48 pregnant women without anemia. FPN1-1355G/C polymorphism were determined using PCR-RFLP method. sTfR and ferritin level were measured with ELISA. Hemoglobin, erythrocyte indices, and sTfR level were compared among genotype group, then statistically analyzed using independent sample t-test and one way ANOVA. Bivariat analysis of Pearson test was conducted to analyze correlation between level of blood Hb and ferritin in pregnant women (p<0.05).

Results: FPN1-1355 G/C polymorphism with frequency in pregnant women with IDA and in pregnant women with anemia non IDA were 100% and 95.2%, respectively (p=0.710; OR=1.600; 95%CI: 0.296-8.653). The mean of Hb level and erythrocyte indices in subjects carrying C allele were lower than subjects carrying only G allele although Hb level is not significantly different (p>0.05). The sTfR and hepcidin level in subjects carrying C allele were higher than subjects carrying only G allele (p<0.05).

Conclusion: In this study the FPN1 gene promoter -1355 G/C polymorphism was not a risk factor for anemia, but it was a risk factor for iron deficiency anemia in pregnant women.

Keywords

polymorphism of ferroportin (FPN1) -1355 G/C; iron deficiency anemia (IDA); soluble transferin receptor (sTfR); ferritin

Full Text:

PDF

References

World Health Organization. Worldwide prevalence of anaemia 1993–2005. Geneva: WHO global database on anaemia; 2008.

Kementrian Kesehatan RI. Profil kesehatan Indonesia. Pusat data dan informasi. Jakarta: Kementerian Kesehatan RI; 2011.

Knutson MD. Iron-sensing proteins that regulate hepcidin and enteric iron absorption. Annu Rev Nutr 2010;30:149-71.

Nemeth E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol 2010;2010:750643.

Kalaivani K. Prevalence & consequences of anaemia in pregnancy. Indian J Med Res 2009;130(5):627-63.

Farmawati A, Istiqomah I, Dewi VS, Umarghanies SS. Anemia defisiensi besi pada ibu hamil: analisis polimorfisme gen ferroportin Q248H dan asupan nutrisi. Laporan Dana Masyarakat. Yogyakarta: Fakultas Kedokteran Universitas Gadjah Mada; 2012.

Panton N. Mutation analysis of four genes implicated in iron homeostasis in porphyria cutanea tarda (PCT) patients [Thesis]. Stellenbosch, South Africa: University of Stellenbosch; 2008.

Bo S, Menato G, Villois P, Gambino R, Cassedar M, Cotrino I, Cavallo-Perin P. Iron supplementation and gestational diabetes in midpregnancy. Am J Obstet Gynecol 2009;201(2):158.e1-6

Bowers K, Yeung E, Williams MA, Qi L, Tobias DK, Hu FB, Zhang C. A prospective study of prepregnancy dietary iron intake and risk for gestational diabetes mellitus. Diabetes Care 2011;34(7):1557-63.

Rivers CA, Barton JC, Gordeuk VR, Acton RT, Speechley MR, Snively BM, Leiendecker-Foster C, Press RD, Adams PC, McLaren GD, Dawkins FW, McLaren CE, Reboussin, DM. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol Dis 2007;38(3):247-52.

Departemen Kesehatan RI. Laporan nasional riset kesehatan dasar 2005. Jakarta: Departemen Kesehatan RI, 2005.

Hallendorff MA. Ironing out haemochromatosis: a study of an Indian family [Thesis]. Stellenbosch, South Africa: University of Stellenbosch; 2008.

Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004;32(1):131-8.

Cui Y, Wu Q, Zhou Y. Iron-refractory iron deficiency anemia: new molecular mechanisms. Kidney Int 2009;76(11):1137-41.

Crichton RR. Iron metabolism-from molecular mechanism to clinical consequences. 3rd ed. UK: John Willey and Sons; 2009.

Lymboussaki A, Pignatti E, Montosi G, Garuti C, Haile DJ, Pietrangelo A. The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. J Hepatol 2003;39(5):710-5.

Akesson A, Bjellerup P, Berglund M, Bremme K, Vahter M. Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am J Clin Nutr 1998;68(6):1241-6.

Wians FH, Urban JE, Keffer JH, Kroft SH. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration. Am J Clin Pathol 2001;115(1):112-8.

Lopez-Sierra M, Calderon S, Gomez J, Pilleux L. Prevalence of anaemia and evaluation of transferrin receptor (sTfR) in the diagnosis of iron deﬁciency in the hospitalized elderly patients: anaemia clinical studies in Chile. Anemia 2012;2012:646201. doi: 10.1155/2012/646201.

Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009;2(2).

Lwanga JB. Serum ferritin levels and birth outcomes for rural pregnant women in Tororo District. Uganda: Child Health and Development Centre Makarere University; 2008.

Van der Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: wich measurements are valid?. Br J Haematol 1998;103(3):817-24.

Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006;1(Suppl 1):S4-8.

Mackenzie EL, Iwasaki K, Tsuji Y. Intracellular iron transport and storage: from molecular mechanism to health implication. Antiox Red Sign 2008;10(6):997-1030.

Ferrucci L, Semba RD, Guralnik JM, Ershler WB, Bandinelli S, Patel KV, Sun K, Woodman RC, Andrews NC, Cotter RJ, Ganz T, Nemeth E, Longo DL. Proinflammatory state, hepcidin, and anemia in older persons. Blood 2010;115(18):3810-6.

Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008;112(10):4292-7.

Jason J, Archibald LK, Nyanyanwu OC, Bell M, Jensen RJ, Gunter E, Buchanan I, Larned J, Kazembe PN, Dobbie H, Jarvis WR. The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost. Clin Exp Immunol 2001;126(3):466-73.

DOI: https://doi.org/10.22146/ijcn.18364